Chinese Lithium Producers' Shares Drop in Wake of Profit Warnings
By Jiahui Huang
Chinese lithium producers' shares fell following forecasts for sharp profit declines in 2023, indicating that slower demand growth from battery and electric-vehicle makers extended into the year's final quarter.
The Hong Kong-listed shares of Ganfeng Lithium were down 3.9% at 21.15 Hong Kong dollars (US$2.70) at midday Wednesday, widening year-to-date losses to 28%. Its Shenzhen-listed shares fell 5.3% to 35.01 yuan (US$4.89).
Tianqi Lithium's H-shares dropped 2.9% to HK$35.55, while its Shenzhen-listed shares shed 5.3%.
Both companies said late Tuesday that they expect to post steep drops in profit amid lower selling prices of lithium products and weakening profit margins.
Ganfeng Lithium expects 2023 net profit to drop 70% to 80%, widening from its 59% drop in bottom-line results through the first nine months of the year. Tianqi forecast a full-year profit decline of 63% to 73%, widening from the nine-month decline of 49%.
At the bottom end of those ranges, both companies would post net losses for the fourth quarter.
Prices of lithium chemical dropped significantly in 2023 due to slower demand growth from battery and EV makers, which dragged on both companies' gross profit margin.
Most recently, Tianqi and joint venture partner IGO agreed to change their pricing mechanism for the Greenbushes lithium mine in Australia, the world's largest hardrock lithium mine in operation.
The new pricing setting will reduce the production cost of the Greenbushes operation. Tianqi's businesses are likely to benefit from the change, Nomura analysts led by Ethan Zhang said.
Write to Jiahui Huang at jiahui.huang@wsj.com
(END) Dow Jones Newswires
January 31, 2024 00:44 ET (05:44 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks